Why is $EWTX moving today? · SEC 8-K archive

$EWTX SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $EWTX: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $EWTX filing catalyst

Why did $EWTX trigger an AI stock catalyst alert?

$EWTX triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.8/10). Headline: Edgewise Therapeutics Q3 Net Income Hits $1.17B on $1.35B Sevasemten Sale Gain. Key points: - Net income reached $1,166M (diluted EPS $9.65) driven by a $1,348M gain on the Sevasemten sale. - Cash, cash equivalents and marketable securities increased to $1,743.9M as of September 30, 2026. - Operating loss narrowed slightly to $46.1M; Phase 3 HCM trial on track for year-end 2026 initiation.

How did $EWTX stock react after the SEC filing?

After the SEC 8-K for $EWTX, observed market reaction: T0 price $37.53. Past moves do not guarantee future results.

Where can I get real-time $EWTX SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $EWTX via Telegram and the VIP Web Terminal from €10/month.

$EWTX

$EWTX – Edgewise Therapeutics Q3 Net Income Hits $1.17B on $1.35B Sevasemten Sale Gain

Edgewise Therapeutics, Inc.

2026-11-04 00:00:00 UTC · SEC 8-K · All $EWTX

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+6.8 / 10)

Net income reached $1,166M (diluted EPS $9.65) driven by a $1,348M gain on the Sevasemten sale.
Cash, cash equivalents and marketable securities increased to $1,743.9M as of September 30, 2026.
Operating loss narrowed slightly to $46.1M; Phase 3 HCM trial on track for year-end 2026 initiation.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →